Oxiquim S.A.

SNSE:OXIQUIM Stock Report

Market Cap: CL$204.1b

Oxiquim Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Oxiquim.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Chemicals earnings growth42.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down

May 25
Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down

Oxiquim's (SNSE:OXIQUIM) Shareholders May Want To Dig Deeper Than Statutory Profit

Apr 07
Oxiquim's (SNSE:OXIQUIM) Shareholders May Want To Dig Deeper Than Statutory Profit

Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?

Jun 10
Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?

Are Dividend Investors Making A Mistake With Oxiquim S.A. (SNSE:OXIQUIM)?

Apr 22
Are Dividend Investors Making A Mistake With Oxiquim S.A. (SNSE:OXIQUIM)?

Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down

Apr 01
Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down

Oxiquim S.A.'s (SNSE:OXIQUIM) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 11
Oxiquim S.A.'s (SNSE:OXIQUIM) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?

Feb 18
Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?

Did You Participate In Any Of Oxiquim's (SNSE:OXIQUIM) Incredible 355% Return?

Jan 27
Did You Participate In Any Of Oxiquim's (SNSE:OXIQUIM) Incredible 355% Return?

Has Oxiquim (SNSE:OXIQUIM) Got What It Takes To Become A Multi-Bagger?

Dec 28
Has Oxiquim (SNSE:OXIQUIM) Got What It Takes To Become A Multi-Bagger?

Oxiquim S.A. (SNSE:OXIQUIM) On An Uptrend: Could Fundamentals Be Driving The Stock?

Dec 07
Oxiquim S.A. (SNSE:OXIQUIM) On An Uptrend: Could Fundamentals Be Driving The Stock?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Oxiquim has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SNSE:OXIQUIM - Analysts future estimates and past financials data (CLP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024228,04026,70018,28729,729N/A
6/30/2024219,23225,30228,32140,192N/A
3/31/2024216,23223,65527,08338,950N/A
12/31/2023214,64923,89627,73940,573N/A
9/30/2023221,90424,93028,07742,743N/A
6/30/2023243,73327,08822,01636,393N/A
3/31/2023258,54727,2208,42523,340N/A
12/31/2022264,69529,2523,44615,979N/A
9/30/2022262,66328,6247,17519,119N/A
6/30/2022238,87425,7101,57811,795N/A
3/31/2022213,13424,8509,03619,582N/A
12/31/2021191,12820,72710,52321,859N/A
9/30/2021170,94718,4717,70123,493N/A
6/30/2021161,25218,27611,14230,618N/A
3/31/2021155,70816,97211,10530,697N/A
12/31/2020158,13517,21911,65633,299N/A
9/30/2020158,11316,7206,49928,481N/A
6/30/2020155,56915,3682,27122,177N/A
3/31/2020155,07515,87411,00328,813N/A
12/31/2019152,02115,61812,25527,042N/A
9/30/2019154,65514,77010,89120,820N/A
6/30/2019157,88116,01818,88828,597N/A
3/31/2019158,87015,2636,88916,451N/A
12/31/2018156,50214,3029,40518,635N/A
9/30/2018151,35113,53414,70521,781N/A
6/30/2018146,84712,685N/A17,028N/A
3/31/2018145,20818,055N/A29,839N/A
12/31/2017144,25318,294N/A25,760N/A
9/30/2017141,72221,842N/A24,332N/A
6/30/2017138,87721,562N/A24,845N/A
3/31/2017135,56616,033N/A22,466N/A
12/31/2016134,43816,492N/A23,811N/A
9/30/2016136,72913,242N/A26,257N/A
6/30/2016140,23813,054N/A23,287N/A
3/31/2016142,59112,493N/A23,350N/A
12/31/2015144,05912,013N/A21,237N/A
9/30/2015144,70810,554N/A28,647N/A
6/30/2015142,7509,386N/A26,275N/A
3/31/2015140,7349,598N/A17,258N/A
12/31/2014140,1198,592N/A21,385N/A
9/30/2014128,1748,715N/A-4,186N/A
6/30/2014129,3777,667N/A4,921N/A
3/31/2014134,5706,195N/A6,617N/A
12/31/2013133,3145,392N/A-562N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if OXIQUIM's forecast earnings growth is above the savings rate (5.5%).

Earnings vs Market: Insufficient data to determine if OXIQUIM's earnings are forecast to grow faster than the CL market

High Growth Earnings: Insufficient data to determine if OXIQUIM's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if OXIQUIM's revenue is forecast to grow faster than the CL market.

High Growth Revenue: Insufficient data to determine if OXIQUIM's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if OXIQUIM's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 06:49
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oxiquim S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution